Acute Myeloid Leukemia Clinical Trial
A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
This research study is evaluating the impact a collaborative palliative care and oncology team will have on the quality of life, symptoms, mood, and end of life outcomes of patients with acute myeloid leukemia (AML). Palliative care is a medical specialty focused on lessening (or "palliating") symptoms and assisting in coping with serious illness.
The main purpose of this study is to compare two types of care - standard leukemia oncology care and standard leukemia oncology care with collaborative involvement of palliative care clinicians to see which is better for improving the experience of patients and families with AML undergoing treatment.
The investigators aim to find out whether introducing patients and families undergoing AML treatment to the palliative care team that specializes in symptom management can improve the physical and psychological symptoms that patients and families experience during their hospitalizations for their leukemia care as well as enhance the quality of patients' end of life care.
Hospitalized patients with high-risk AML, defined as:
Newly diagnosed patients with AML ≥ 60 years of age
Newly diagnosed AML with antecedent hematologic disorder
Newly diagnosed therapy-related AML
Primary refractory AML
Patients already receiving palliative care
Major psychiatric illness or comorbid conditions prohibiting compliance with study procedures.
A diagnosis of acute promyelocytic leukemia (APML)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 4 Locations for this study
Boston Massachusetts, 02114, United States
Durham North Carolina, 27710, United States
Columbus Ohio, 43210, United States
Philadelphia Pennsylvania, 16802, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.